TeiaCare

Founded in 2018, TeiaCare focuses on using AI to improve care quality, operational efficiency, and sustainability in nursing homes and residential care settings. The company positions itself as a technology partner for care providers facing challenges linked to aging populations and workforce shortages. TeiaCare was founded in 2018 by Guido Magrin and Luca Iozzia, following firsthand exposure to inefficiencies within residential care environments. In March 2026, TeiaCare raised EUR 7 million in venture funding led by new investor P101 SGR, with participation from other new investors Namarel Ventures and Inderhabs Investments.

TeiaCare’s flagship product, Ancelia, is an AI‑powered care monitoring platform that uses optical sensors and advanced algorithms to continuously observe care environments. The system transforms real‑time data into actionable insights that help caregivers prevent risks, personalize care, and support managers in optimizing resources and workflows. The company generates revenue primarily through the sale and deployment of its Ancelia software platform, typically offered to residential care providers under commercial agreements. Revenue is linked to technology licensing and ongoing service and support for care facilities adopting its AI‑based monitoring solutions.

In the most recent year, 2022, TeiaCare reported a revenue of EUR 2,204,782. 30, with an EBITDA of EUR 58,532. 20 for the same year. Revenue is generated through partnerships and direct transactions with healthcare facilities utilizing the ANCELIA solution, likely based on subscription fees for access to the system and ongoing support services.

The company will use the March 2026 funding to support the company’s business expansion and the continued development of its healthcare technology platform.